Abacavir
Abacavir, ZIAGEN
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$0.6524
No Shortage
Tier 1: 39.8%
5 Manufacturers
7 ANDAs
Abacavir blocks HIV replication by inhibiting reverse transcriptase.
vs. brand Abacavir: Generic saves up to 93% per unit
Generic Manufacturers
AUROBINDO PHARMA LTDCHARTWELL RX SCIENCES LLCCIPLA LTDHETERO LABS LTD UNIT IIIMYLAN PHARMACEUTICALS INCVIIV HEALTHCARE CO
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
